Insulin glargine and lixisenatide and Scopolamine (Systemic)
Determining the interaction of Insulin glargine and lixisenatide and Scopolamine (Systemic) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
Generic Name: scopolamine
Brand name: Transderm-Scop
Synonyms: Scopolamine transdermal
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide-Scopolamine Hydrobromide
- Insulin glargine and lixisenatide-Scopolamine Injection
- Insulin glargine and lixisenatide-Scopolamine Patch
- Insulin glargine and lixisenatide-Scopolamine transdermal
- Insulin glargine and lixisenatide-Scopolamine Transdermal Patch
- Insulin glargine and lixisenatide-Scot-Tussin Allergy Relief Formula
- Scopolamine (Systemic)-Insulin glargine and lixisenatide Subcutaneous
- Scopolamine (Systemic)-Insulin glargine, recombinant Subcutaneous
- Scopolamine (Systemic)-Insulin glulisine
- Scopolamine (Systemic)-Insulin Glulisine (Cartridges and Pens)
- Scopolamine (Systemic)-Insulin Glulisine (Vials)
- Scopolamine (Systemic)-Insulin glulisine Subcutaneous